TipRanks
Iperionx Limited (AU:IPX)
ASX:IPX
Want to see AU:IPX full AI Analyst Report?

Iperionx Limited (IPX) AI Stock Analysis

169 Followers

Top Page

AU:IPX

Iperionx Limited

(Sydney:IPX)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - Gpt-5.6Sol)
Rating:42Neutral
Price Target:
AU$1.50
▼(-50.82% Downside)
Action:Reiterated
Date:09/30/26
The score is held down primarily by weak financial performance (no revenue, widening losses, and accelerating cash burn). Technicals reinforce the risk with a clear downtrend and negative momentum signals, while valuation remains unattractive/unclear due to a negative P/E and no dividend support.
Positive Factors
Domestic Titanium Supply Chain
A domestic U.S. titanium chain could position IperionX near aerospace, defense, and advanced-manufacturing demand. If execution succeeds, a local platform may create durable strategic relevance and support customer relationships beyond a single product cycle.
Negative Factors
No Reported Revenue
A sustained absence of reported revenue means IperionX has not yet demonstrated commercial monetization of its titanium strategy. This leaves future funding and value creation dependent on successfully reaching production, qualification, and customer-sales milestones.
Read all positive and negative factors
Positive Factors
Negative Factors
Domestic Titanium Supply Chain
A domestic U.S. titanium chain could position IperionX near aerospace, defense, and advanced-manufacturing demand. If execution succeeds, a local platform may create durable strategic relevance and support customer relationships beyond a single product cycle.
Read all positive factors

Iperionx Limited (IPX) vs. iShares MSCI Australia ETF (EWA)

Iperionx Limited Business Overview & Revenue Model

Company Description
IperionX Limited engages in the development of its mineral properties in the United States. It holds a 100% interest in the critical minerals Titan project, which has resources of titanium, zircon, and rare earth mineral resources in Tennessee, th...
How the Company Makes Money
IperionX’s primary monetization pathway is to generate revenue by selling titanium metal products (e.g., titanium powder and/or other titanium forms) to customers that use titanium in manufacturing (such as aerospace, defense, and industrial buyer...

Iperionx Limited Financial Statement Overview

Summary
Overall financials indicate a pre-revenue, cash-burning profile: the income statement shows zero revenue with widening losses, and cash flow shows accelerating operating and free cash outflows. The balance sheet is a relative strength with low leverage and a much larger equity base, but profitability and cash sustainability remain the dominant risks.
Income Statement
12
Very Negative
Balance Sheet
62
Positive
Cash Flow
18
Very Negative
BreakdownJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue0.000.000.000.000.00
Gross Profit-4.28M―-657.16K-634.11K-153.34K
EBITDA-64.36M―-21.97M-17.24M-21.70M
Net Income-65.75M-35.35M-22.23M-17.72M-21.52M
Balance Sheet
Total Assets105.71M105.03M55.44M22.80M9.91M
Cash, Cash Equivalents and Short-Term Investments35.23M54.81M33.16M11.94M5.67M
Total Debt4.16M3.93M1.49M975.31K543.03K
Total Liabilities17.44M12.59M4.10M2.24M2.49M
Stockholders Equity88.26M92.44M51.34M20.56M7.42M
Cash Flow
Free Cash Flow-61.78M-39.41M-26.68M-18.57M-14.06M
Operating Cash Flow-44.27M-21.80M-18.61M-15.86M-12.13M
Investing Cash Flow-18.28M-24.28M-6.53M-5.71M-3.07M
Financing Cash Flow42.52M67.99M46.59M27.89M19.39M

Iperionx Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price3.05
Price Trends
50DMA
2.65
Negative
100DMA
3.25
Negative
200DMA
4.37
Negative
Market Momentum
MACD
-0.24
Positive
RSI
28.52
Positive
STOCH
3.38
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:IPX, the sentiment is Negative. The current price of 3.05 is above the 20-day moving average (MA) of 2.21, above the 50-day MA of 2.65, and below the 200-day MA of 4.37, indicating a bearish trend. The MACD of -0.24 indicates Positive momentum. The RSI at 28.52 is Positive, neither overbought nor oversold. The STOCH value of 3.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:IPX.

Iperionx Limited Risk Analysis

Iperionx Limited disclosed 51 risk factors in its most recent earnings report. Iperionx Limited reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Iperionx Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
51
Neutral
AU$25.27M-13.69-13.41%――37.54%
47
Neutral
AU$1.64B17.3229.67%―――
44
Neutral
AU$1.38B240.915.65%―150.47%―
43
Neutral
AU$476.37M-5.95-52.04%―――
42
Neutral
AU$642.98M-6.26-67.95%――-57.92%
42
Neutral
AU$495.41M-2.24-7.06%―-33.21%-21.79%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:IPX
Iperionx Limited
1.78
-5.39
-75.21%
AU:EQR
EQ Resources Limited
0.27
0.22
476.09%
AU:MI6
Minerals 260 Limited
0.66
0.36
120.00%
AU:VUL
Vulcan Energy Resources Ltd.
1.04
-4.27
-80.49%
AU:HTM
High-Tech Metals Limited
0.24
-0.08
-25.00%
AU:BRE
Brazilian Rare Earths Ltd.
1.73
-3.53
-67.14%

Iperionx Limited Corporate Events

IperionX Director Repays Loan, Retrieves Collateral Shares With No Change in Ownership
Sep 30, 2026
IperionX Limited has disclosed that director Anastasios Arima has effected an off-market return of 1,000,000 fully paid ordinary shares that were previously pledged as collateral under a loan facility, following repayment of that loan. The transac...
IperionX Files Governance Disclosure Appendix 4G with ASX
Sep 28, 2026
IperionX Limited has lodged its Appendix 4G with the ASX, outlining how investors can access its corporate governance statement for the financial year ended 30 June 2026. The statement, hosted on the company’s website and approved by the boa...
IperionX Sets 2026 AGM Date and Deadline for Director Nominations
Sep 28, 2026
IperionX Limited has scheduled its 2026 Annual General Meeting for November 25 in line with ASX governance requirements, setting the stage for key corporate decisions. The meeting will include the election of directors, a core element of the compa...
IperionX Validates High‑Efficiency GenX Continuous Titanium Production
Sep 15, 2026
IperionX has validated its GenX™ continuous HAMR™ titanium production platform at commercial scale, processing more than 500 kg of titanium powder in four campaigns at its Virginia RD facility. All valid product samples met stringent A...
IperionX Wins Second U.S. Army Task Order to Scale Domestic Titanium Production
Aug 31, 2026
IperionX has secured a second task order from the U.S. Army under its US$99 million SBIR Phase III contract for low-cost domestic titanium, with US$11.5 million currently funded and a potential value of up to US$25.4 million. The firm-fixed-price ...
Iperionx Issues New Unquoted Equity Awards Under Employee Incentive Scheme
Aug 7, 2026
Iperionx Limited has notified the market of the issue of 58,584 restricted stock units and 947,062 unquoted options under its employee incentive scheme, with the options expiring in August 2030 at an exercise price of $11.00. The move expands the ...
IperionX Appoints Michael Loparco as Director and Discloses RSU Holding
Aug 7, 2026
IperionX Limited has announced the appointment of Michael Loparco as a director effective August 3, 2026. As part of his initial disclosed interests, Loparco holds 58,584 restricted stock units in the company, expiring on August 3, 2028, and curre...
Iperionx Reaffirms Critical Minerals Platform and Project Assumptions
Aug 4, 2026
Iperionx Limited has released a webinar presentation outlining its role as a U.S. critical minerals-to-metals supplier for strategic industries including defense, aerospace, nuclear, semiconductors, robotics and advanced manufacturing. The company...
IperionX to Shift Legal Home to Texas and Bolster Board for U.S. Titanium Push
Aug 2, 2026
IperionX plans to redomicile its ultimate parent company to Texas, aligning its legal and capital-markets structure with its U.S.-based manufacturing, critical minerals and technology operations. The move is designed to match its principal assets ...
IperionX Schedules Investor Webinar for Early August
Jul 31, 2026
IperionX Limited has scheduled an investor webinar to provide a company update, featuring Founder and CEO Taso Arima as presenter. The event will be held via Zoom on August 5, 2026 at 8:00 a.m. AEST, which corresponds to August 4, 2026 at 6:00 p.m...
IperionX ramps titanium operations, secures U.S. backing for expansion
Jul 29, 2026
IperionX reported continued 24/7 titanium powder operations in Virginia, with HAMR™ production meeting or exceeding grade 5 standards and supporting customer qualification programs, while progressing development of its next-generation GenX&#...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 30, 2026